Veteran immunologist and former Pfizer R&D leader joins Circurna to advance its circular RNA therapeutic platform ...

Scientists have discovered a new CRISPR mechanism with precise activity, expanding the potential applications of the existing ...

First-in-human study evaluates safety, pharmacokinetics, biomarker analyses, target engagement, and anti-tumor activity in ...

A new study shows human immune systems differ across populations, raising new questions for medicine and global drug research ...

During the first few years of the COVID-19 pandemic, the virus SARS-CoV-2 was detected in an increasing number of non-human ...

Although the year brought a steady stream of new treatments, tests, and cutting-edge science, experts worry about how ...

Aperture Therapeutics is advancing APRTX-003, an RNA-based antisense therapy targeting MMP9, as a potential ALS treatment.

Plant viruses pose a serious and ongoing threat to global agriculture in tropical to temperate regions. Among the most damaging are begomoviruses, a group of DNA viruses spread by whiteflies that ...

In the same week that Servier announced its partnership with Paris, France-based Iktos, now Pierre Fabre Laboratories has ...

Scientists at the Icahn School of Medicine at Mount Sinai, in partnership with the Multiple Myeloma Research Foundation (MMRF ...

EQT Foundation has invested in UK-based Biographica as part of its seed round, supporting the company’s machine learning platform for faster and more accurate crop gene discovery. Biographica’s ...